Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 16/20 | 1.00 |
| ▸ | CNR1 | P21554 | 14/20 | 1.00 |
| ▸ | TRPM8 | Q7Z2W7 | 2/20 | 1.00 |
| ▸ | GPR55 | Q9Y2T6 | 2/20 | 1.00 |
| ▸ | TRPA1 | O75762 | 1/20 | 1.00 |
| ▸ | HTR1A | P08908 | 1/20 | 1.00 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 1.00 |
| ▸ | TRPV3 | Q8NET8 | 1/20 | 1.00 |
| ▸ | TRPV6 | Q9H1D0 | 1/20 | 1.00 |
| ▸ | TRPV4 | Q9HBA0 | 1/20 | 1.00 |
| ▸ | TRPV5 | Q9NQA5 | 1/20 | 1.00 |
| ▸ | TRPV2 | Q9Y5S1 | 1/20 | 1.00 |
| ▸ | ABHD12 | Q8N2K0 | 3/20 | 0.86 |
| ▸ | ABHD6 | Q9BV23 | 3/20 | 0.86 |
| ▸ | FAAH | O00519 | 2/20 | 0.86 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.86 |
| ▸ | LDHA | P00338 | 1/20 | 0.86 |
| ▸ | GLRA1 | P23415 | 1/20 | 0.86 |
| ▸ | GPR183 | P32249 | 1/20 | 0.86 |
| ▸ | DRD3 | P35462 | 1/20 | 0.86 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Tetrahydrocannabivarin SCHEMBL29904669 | 1.00 | CNR2 (1.00) | CNR2CNR1TRPM8GPR55TRPA1 | |
| Tetrahydrocannabivarin SCHEMBL29422123 | 1.00 | CNR2 (1.00) | CNR2CNR1TRPM8GPR55TRPA1 | |
| Tetrahydrocannabivarin SCHEMBL30017852 | 1.00 | CNR2 (1.00) | CNR2CNR1TRPM8GPR55TRPA1 | |
| Tetrahydrocannabivarin SCHEMBL31300003 | 1.00 | CNR2 (1.00) | CNR2CNR1TRPM8GPR55TRPA1 | |
| Tetrahydrocannabivarin SCHEMBL31544930 | 1.00 | CNR2 (1.00) | CNR2CNR1TRPM8GPR55TRPA1 | |
| Tetrahydrocannabivarin SCHEMBL18371743 | 1.00 | CNR2 (1.00) | CNR2CNR1TRPM8GPR55TRPA1 | |
| Tetrahydrocannabivarin SCHEMBL6856739 | 1.00 | CNR2 (1.00) | CNR2CNR1TRPM8GPR55TRPA1 | |
| Tetrahydrocannabivarin SCHEMBL245827 | 1.00 | CNR2 (1.00) | CNR2CNR1TRPM8GPR55TRPA1 | |
| Tetrahydrocannabivarin SCHEMBL21363566 | 1.00 | CNR2 (1.00) | CNR2CNR1TRPM8GPR55TRPA1 | |
| Tetrahydrocannabivarin SCHEMBL25731794 | 1.00 | CNR2 (1.00) | CNR2CNR1TRPM8GPR55TRPA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 5650 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4412609-B1 | ALKOXYLATION OF CANNABIDIOL & OTHER CANNABINOIDS | INDORAMA VENTURES OXIDES LLC (US) | 2026-05-27 | — | — | EP | claimed |
| US-12636251-B1 | Glycoside-containing aqueous formulations having a lipophilic active component | Doane Technology Group LLC (US) | 2026-05-26 | — | — | US | claimed |
| EP-4742916-A1 | HEMP PROTEIN PRODUCTS HAVING A NEUTRAL OR NEAR NEUTRAL PH AND A REDUCED SALT CONTENT | Burcon Nutrascience (MB) Corp. (CA) | 2026-05-20 | — | — | EP | claimed |
| US-12629332-B2 | Cannabinoid chewing gum with sugar alcohols | NORDICCAN A/S (DK) | 2026-05-19 | — | — | US | claimed |
| US-12629383-B2 | Cannabinoid compositions with high solubility and bioavailability | PISAK MEHMET NEVZAT (TR) | 2026-05-19 | — | — | US | claimed |
| EP-4291170-B1 | USE OF CANNABIDIVARIN IN THE TREATMENT OF SEIZURES ASSOCIATED WITH CANINE EPILEPSY | JAZZ PHARMACEUTICALS RESEARCH UK LTD (GB) | 2026-05-13 | — | — | EP | claimed |
| EP-4739284-A1 | AN ADHESIVE ORAL DISC FOR SUSTAINED RELEASE OF CANNABINOIDS | Fertin Pharma A/S (DK) | 2026-05-13 | — | — | EP | claimed |
| EP-4734961-A1 | NEW METHOD OF PRODUCING AN AQUEOUS MESOPARTICLE COMPOSITION COMPRISING A LIPOPHILIC COMPOUND | BIOGNTX R&D B.V. (NL) | 2026-05-06 | — | — | EP | claimed |
| EP-4734974-A1 | CANNABINOID COMPOSITION FOR USE IN THE TREATMENT OF PAIN AND/OR INFLAMMATION | Mabewo Phytopharm AG (CH) | 2026-05-06 | — | — | EP | claimed |
| US-12616728-B2 | Processes and systems for converting cannabinoids into cannabinoid derivatives and isolating the same | SUPER CRITICAL IP, LLC (US) | 2026-05-05 | — | — | US | claimed |
| CN-110632224-B | Establishment method of hemp plant fingerprint spectrum | 福建省中科生物股份有限公司 | 2022-02-15 | — | — | CN | claimed |
| US-11246852-B2 | Fast-acting plant-based medicinal compounds and nutritional supplements | RECEPTOR HOLDINGS, INC. (US) | 2022-02-15 | — | — | US | claimed |
| CN-114025605-A | Method for producing transgenic seeds | 林家明 | 2022-02-08 | — | — | CN | claimed |
| CN-109568389-B | Preparation method of high-purity cannabinol extract | 汉义生物科技（北京）有限公司 | 2022-02-08 | — | — | CN | claimed |
| WO-2022027053-A1 | MICELLE PREPARATIONS OF FULL-SPECTRUM HEMP OIL FOR TREATING TYPE II DIABETES, REDUCING INFLAMMATION DURING COVID-19, AND IMPROVING SLEEP QUALITY | WSMEF, LLC (US) | 2022-02-03 | — | — | WO | claimed |
| WO-2022026613-A2 | METHODS AND COMPOSITIONS FOR ALTERING SECONDARY METABOLITES IN PLANTS | IMPELLO BIOSCIENCES, INC. (US) | 2022-02-03 | — | — | WO | claimed |
| US-20220023771-A1 | EXTRACTION METHOD AND COMPOSITION OBTAINED THEREFROM | NATURALIA INGREDIENTS S.R.L. (IT) | 2022-01-27 | — | — | US | claimed |
| WO-2022018754-A1 | INTERACTION OF SARS-COV-2 PROTEINS WITH MOLECULAR AND CELLULAR MECHANISMS OF HOST CELLS AND FORMULATIONS TO TREAT COVID-19. | AKSEERA PHARMA CORP. (CA) | 2022-01-27 | — | — | WO | claimed |
| US-11229612-B2 | Parenteral formulations | GW Research Limited (GB) | 2022-01-25 | — | — | US | claimed |
| CN-113966213-A | Self-emulsifying drug delivery system for delivery of lipophilic compounds | 耶路撒冷希伯来大学伊森姆研究发展有限公司 | 2022-01-21 | — | — | CN | claimed |